Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-α signaling in the pancreas of rats on a high-fat diet

Nutrition Research

Volumn 34, Issue 12, 2014, Pages 1066-1074

  Cao, Yanli ^a   Bao, Suqing ^a   Yang, Wanli ^a   Zhang, Jin ^a   Li, Lin ^a   Shan, Zhongyan ^a   Teng, Weiping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Epigallocatechin gallate; Inflammation; Obesity; Pancreas; Rat

Indexed keywords

EPIGALLOCATECHIN GALLATE; FATTY ACID; GLUCOSE; INSULIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; AUTACOID; CATECHIN; CD68 ANTIGEN, HUMAN; CYTOKINE; DIFFERENTIATION ANTIGEN; GLUCOSE BLOOD LEVEL; LEUKOCYTE ANTIGEN; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY MASS; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HISTOLOGY; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE INDEX; INSULIN RELEASE; INSULIN SENSITIVITY; MACROPHAGE; MALE; METABOLIC PARAMETERS; NONHUMAN; PANCREAS ISLET CELL; PANCREATITIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT DURATION; WESTERN BLOTTING; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; DRUG EFFECTS; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; METABOLISM; PANCREAS; PANCREAS ISLET; PATHOLOGY; PHYTOTHERAPY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOOD GLUCOSE; CATECHIN; CYTOKINES; DIET, HIGH-FAT; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MACROPHAGES; MALE; PANCREAS; PHYTOTHERAPY; PLANT EXTRACTS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919455324     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2014.10.004     Document Type: Article

References (54)

1. Kramer C.K., Zinman B., Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med 2013, 159:758-769.
2. Klop B., Elte J.W., Cabezas M.C. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013, 5:1218-1240.
3. Gupta D., Krueger C.B., Lastra G. Over-nutrition. Obesity and insulin resistance in the development of β-cell dysfunction. Curr Diabetes Rev 2012, 8:76-83.
4. Montane J., Cadavez L., Novials A. Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes. Diabetes Metab Syndr Obes 2014, 7:25-34.
5. Rabinovitch A., Suarez-Pinzon W.L. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998, 55:1139-1149.
6. Odegaard J.I., Chawla A. Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb Perspect Med 2012, 2:a007724. [in press].
7. Davis J.E., Gabler N.K., Walker-Daniels J., Spurlock M.E. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 2008, 16:1248-1255.
8. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009, 21:317-337.
9. Suganami T., Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 2010, 88:33-39.
10. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
11. Youssef-Elabd E.M., McGee K.C., Tripathi G., Aldaghri N., Abdalla M.S., Sharada H.M., et al. Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro. J Nutr Biochem 2012, 23:39-50.
12. Tian Y.F., He C.T., Chen Y.T., Hsieh P.S. Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats. World J Gastroenterol 2013, 19:2761-2771.
13. Eguchi K., Manabe I., Oishi-Tanaka Y., Ohsugi M., Kono N., Ogata F., et al. Saturated fatty acid and TLR signaling link β-cell dysfunction and islet inflammation. Cell Metab 2012, 15:518-533.
14. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001, 276:16683-16689.
15. Richardson S.J., Willcox A., Bone A.J., Foulis A.K., Morgan N.G. Islet-associated macrophages in type 2 diabetes. Diabetologia 2009, 52:1686-1688.
16. Ladefoged M., Buschard K., Hansen A.M. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes. APMIS 2013, 121:531-538.
17. Qi H.Y., Shelhamer J.H. Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J Biol Chem 2005, 280:38969-38975.
18. Goldberg A., Parolini M., Chin B.Y., Czismadia E., Otterbein L.E., Bach F.H., et al. Toll-like receptor 4 suppression leads to islet allograft survival. FASEB J 2007, 21:2840-2848.
19. Schulthess F.T., Paroni F., Sauter N.S., Shu L., Ribaux P., Haataja L., et al. CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab 2009, 9:125-139.
20. Yang G.Y., Liao J., Li C., Chung J., Yurkow E.J., Ho C.T., et al. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 2000, 21:2035-2039.
21. Wolfram S., Wang Y., Thielecke F. Anti-obesity effects of green tea: from bedside to bench. Mol Nutr Food Res 2006, 50:176-187.
22. Sae-tan S., Grove K.A., Lambert J.D. Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res 2011, 64:146-154.
23. Dickinson D., Derossi S., Yu H., Thomas C., Kragor C., Paquin B., et al. Epigallocatechin-3-gallate modulates anti-oxidant defense enzyme expression in murine submandibular and pancreatic exocrine gland cells and human HSG cells. Autoimmunity 2014, 47:177-184.
24. Hara Y., Fujino M., Takeuchi M., Li X.K. Green-tea polyphenol (-)- epigallocatechin-3-gallate provides resistance to apoptosis in isolated islets. J Hepatobiliary Pancreat Surg 2007, 14:493-497.
25. Cha K.H., Song D.G., Kim S.M., Pan C.H. Inhibition of gastrointestinal lipolysis by green tea, coffee, and gomchui (Ligularia fischeri) tea polyphenols during simulated digestion. J Agric Food Chem 2012, 60:7152-7157.
26. Cai E.P., Lin J.K. Epigallocatechingallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells. J Agric Food Chem 2009, 57:9817-9827.
27. Bose M., Lambert J.D., Ju J., Reuhl K.R., Shapses S.A., Yang C.S. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 2008, 138:1677-1683.
28. Li X., Yuan L., Li J., Li H., Cheng S. Blockade of renin angiotensin system increased resistance to STZ-induced diabetes in rats with long-term high-fat diet. Exp Diabetes Res 2012, 10.1155/2012/618923.
29. Cancello R., Tordjman J., Poitou C., Guilhem G., Bouillot J.L., Hugol D. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006, 55:1554-1561.
30. Chan C.Y., Wei L., Castro-Muñozledo F., Koo W.L. (-)-Epigallocatechin- 3-gallateblocks 3T3-L1 adipose conversion by inhibition of cell proliferation and suppression of adipose phenotype expression. Life Sci 2011, 89:779-785.
31. Schaeffler A., Gross P., Buettner R., Bollheimer C., Buechler C., Neumeier M., et al. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 2009, 126:233-245.
32. Sang S., Yang I., Buckley B., Ho C.T., Yang C.S. Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate: studied by real-time mass spectrometry combined with tandem mass ion mapping. Free Radic Biol Med 2007, 43:362-371.
33. Kida K., Suzuki M., Matsumoto N., Nanjo F., Hara Y. Identification of biliary metabolites of (-)-epigallocatechin gallate in rats. J Agric Food Chem 2000, 48:4151-4155.
34. Wang S., Moustaid-Moussa N., Chen L., Mo H., Shastri A., Su R., et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem 2014, 25:1-18.
35. Maki K.C., Reeves M.S., Farmer M., Yasunaga K., Matsuo N., Katsuragi Y., et al. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr 2009, 139:264-270.
36. Bogdanski P., Suliburska J., Szulinska M., Stepien M., Pupek-Musialik D., Jablecka A. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res 2012, 32:421-427.
37. Klaus S., Pültz S., Thöne-Reineke C., Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) 2005, 29:615-623.
38. Chen Y.K., Cheung C., Reuhl K.R., Liu A.B., Lee M.J., Lu Y.P., et al. Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice. J Agric Food Chem 2011, 59:11862-11871.
39. Mlinar B., Marc J., Janez A., Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 2007, 375:20-35.
40. Geloneze B., Tambascia M.A. Laboratorial evaluation and diagnosis of insulin resistance. Arq Bras Endocrinol Metabol 2006, 50:208-215.
41. Cnop M., Welsh N., Jonas J.C., Jörns A., Lenzen S., Eizirik D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005, 54:S97-S107.
42. Pavan Kumar P., Radhika G., Rao G.V., Pradeep R., Subramanyam C., Talukdar R., et al. Interferon γ and glycemic status in diabetes associated with chronic pancreatitis. Pancreatology 2012, 12:65-70.
43. Zhang Z., Ding Y., Dai X., Wang J., Li Y. Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur J Pharmacol 2011, 670:311-316.
44. Han M.K. Epigallocatechingallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp Mol Med 2003, 35:136-139.
45. Fu Z., Zhen W., Yuskavage J., Liu D. Epigallocatechingallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice. Br J Nutr 2011, 105:1218-1225.
46. Poggi M., Bastelica D., Gual P., Iglesias M.A., Gremeaux T., Knauf C., et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007, 50:1267-1276.
47. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B., Prada P.O., Hirabara S.M., Schenka A.A., et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56:1986-1998.
48. Kim F., Pham M., Luttrell I., Bannerman D.D., Tupper J., Thaler J., et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 2007, 100:1589-1596.
49. Pal D., Dasgupta S., Kundu R., Maitra S., Das G. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 2012, 18:1279-1285.
50. Bao S., Cao Y., Fan C., Fan Y., Shan Z., Teng W., et al. Epigallocatechingallate improves insulin signaling by decreasing toll-like receptor 4 (TLR4) activity in adipose tissues of high-fat diet rats. Mol Nutr Food Res 2014, 58:677-686.
51. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010, 72:219-246.
52. Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol Rev 2011, 240:92-104.
53. Xu Y., Jagannath C., Liu X.D., Sharafkhaneh A., Kolodziejska K.E., Eissa N.T. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007, 27:135-144.
54. Delgado M.A., Elmaoued R.A., Davis A.S., Kyei G., Deretic V. Toll-like receptors control autophagy. EMBO J 2008, 27:1110-1121.